OI
PRAH

Oakbrook Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

Oakbrook Investments’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,800
Closed -$756K – 567
2019
Q4 		$756K Sell
6,800
-900
-12% -$92.6K 0.15% 196
2019
Q3 		$764K Buy
7,700
+400
+5% +$39.7K 0.05% 295
2019
Q2 		$724K Buy
7,300
+3,850
+112% +$367K 0.04% 320
2019
Q1 		$381K Hold
3,450
– – 0.02% 446
2018
Q4 		$317K Sell
3,450
-450
-12% -$45.5K 0.02% 461
2018
Q3 		$430K Buy
3,900
+1,250
+47% +$130K 0.02% 473
2018
Q2 		$247K Buy
+2,650
New +$228K 0.02% 497

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Oakbrook Investments's PRAH Position: Q1 2020 in Review

Oakbrook Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 6,800 shares — an estimated $756K sold.

Oakbrook Investments first reported a position in PRAH in Q2 2018 and held it in 7 quarters. The position peaked at $764K in Q3 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Oakbrook Investments reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 6,800 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $756K.
  • Oakbrook Investments first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 7 quarters.
  • Oakbrook Investments's PRA Health Sciences, Inc. position peaked at $764K in Q3 2019.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.